"Abbreviated" NAD+ analogues with anionic phosphonate function as a part of the link between the adenine and nicotinamide moieties, 9-(2-phosphonomethoxyethyl)adenine 2-(3-carbamoylpyridinium)ethyl ester (1a), (R)- and (S)-9-(2-phosphonomethoxypropyl)adenine 2-(3-carbamoylpyridinium)ethyl ester (1b and 1c), (RS)-9-(3-hydroxy-2-phosphonomethoxypropyl)adenine 2-(3-carbamoylpyridinium)ethyl ester (1d), and (S)- and (R)-1-[3-(adenin-9-yl)-2-phosphonatomethoxypropyl]-3-carbamoylpyridinium (2a and 2b), were prepared by multistep syntheses using the Zincke reaction in the last step.
使用带有阴离子
磷酸酯功能的“缩写”
NAD+类似物作为
腺嘌呤和烟酰胺基团之间的连接部分,通过多步合成使用Zincke反应在最后一步制备了9-(2-
磷酸甲氧基乙基)
腺嘌呤 2-(3-
氨甲基吡啶)
乙酯(1a)、(R)-和(S)-9-(2-
磷酸甲氧基丙基)
腺嘌呤 2-(3-
氨甲基吡啶)
乙酯(1b和1c)、(RS)-9-(3-羟基-2-
磷酸甲氧基丙基)
腺嘌呤 2-(3-
氨甲基吡啶)
乙酯(1d),以及(S)-和(R)-1-[3-(
腺嘌呤-9-基)-2-
磷酸甲氧基丙基]-3-
氨甲基吡啶(2a和2b)。